Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication December 21, 2005
- Revision received June 7, 2006
- Accepted for publication June 26, 2006
- Published online January 29, 2007.
Copyright & Usage
© 2007 Annals of Family Medicine, Inc.
Author Information
- Dominick L. Frosch, PhD1,2,
- Patrick M. Krueger, PhD3,4,
- Robert C. Hornik, PhD2,5,
- Peter F. Cronholm, MD, MSCE6 and
- Frances K. Barg, PhD6
- 1Department of Medicine, University of California, Los Angeles, Los Angeles, Calif
- 2Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pa
- 3School of Public Health, University of Texas Health Science Center at Houston, Houston, Tex
- 4Population Research Center, University of Texas at Austin, Austin, Tex
- 5Department of Medicine, University of Pennsylvania, Philadelphia, Pa
- 6Annenberg School for Communication, University of Pennsylvania, Philadelphia, Pa
- 7Department of Family Medicine & Community Health, University of Pennsylvania, Philadelphia, Pa
- CORRESPONDING AUTHOR: Dominick L. Frosch, PhD, Department of Medicine, University of California, Los Angeles, 911 Broxton Plaza, Los Angeles, CA 90095-1736, dfrosch{at}mednet.ucla.edu
A version of this report was presented at the 27th annual meeting of the Society for Medical Decision Making, San Francisco, Calif, 22 October 2005.
Statistics from Altmetric.com
Article usage
Jump to section
Related Articles
Cited By...
- US FDA breakthrough therapy designation and consumer drug advertising: a recipe for confusion
- Quality of advertisements for prescription drugs in family practice medical journals published in Australia, Canada and the USA with different regulatory controls: a cross-sectional study
- In This Issue: Sometimes More is Less
- An Updated Analysis of Direct-to-Consumer Television Advertisements for Prescription Drugs
- Ethical drug marketing criteria for the 21st century
- 'At-risk individuals responses to direct to consumer advertising of prescription drugs: a nationally representative cross-sectional study
- The Politics and Strategy of Industry Self-Regulation: The Pharmaceutical Industry's Principles for Ethical Direct-to-Consumer Advertising as a Deceptive Blocking Strategy
- Effects of Funding Policy Changes and Health Warnings on the Use of Erythropoiesis-Stimulating Agents
- Relationships with the drug industry: More regulation, greater transparency
- Should Canada allow direct-to-consumer advertising of prescription drugs?: NO
- Le Canada devrait-il autoriser la publicite directe des medicaments d'ordonnance?: NON
- Lack of Impact of Direct-to-Consumer Advertising on the Physician-Patient Encounter in Primary Care: A SNOCAP Report
- Direct to consumer advertising of prescription drugs
- On TRACK: Primary Care Opportunities for Filling Unmet Need
- On TRACK: Intended and Unintended Consequences of Direct-to-Consumer Drug Marketing
- Time to Ban Direct-to-Consumer Prescription Drug Marketing
- Direct-to-Consumer Advertising: Is It Too Late to Manage the Risks?
- In This Issue: Doctor-Patient and Drug Company-Patient Communication